H15.05
Scleromalacia perforans
Clinical Classification Guidelines
Medical Intelligence & Overview
Scleromalacia perforans is a rare eye condition characterized by thinning and degradation of the sclera, the white outer layer of the eyeball. Unlike other forms of scleral thinning, this condition typically progresses slowly and may not cause significant discomfort in its early stages. However, as the sclera weakens, it can lead to serious complications such as scleral rupture or perforation, which may threaten vision if not properly managed. Recognizing the signs, causes, and treatment options is essential for maintaining eye health and preventing potential vision loss.
Causes & Symptoms
Clinical Causes: Autoimmune diseases, notably rheumatoid arthritis, which can cause inflammation of the sclera Inflammatory ocular conditions that lead to scleral weakening Infections affecting the sclera, although less common Genetic disorders that predispose structural weakness of ocular tissues Trauma or previous eye surgery resulting in scleral damage Idiopathic cases where no clear cause is identified
Key Symptoms: Gradual or sometimes rapid loss of visual clarity Visible thinning of the sclera, sometimes noticeable as bluish or greyish patches on the white of the eye Mild discomfort or irritation, often painless in early stages Bulging of the uveal tissue through the thinned sclera in advanced cases Possible eye redness coupled with swelling or inflammation In rare instances, scleral perforation leading to ocular contents protruding
Diagnostic & Treatment
Diagnosis Path: Diagnosis involves a comprehensive eye examination by an ophthalmologist. Key aspects include: - Slit-lamp examination to observe scleral thinning and opacity - Evaluation of visual acuity and intraocular pressure - Imaging techniques such as ultrasound biomicroscopy or ocular coherence tomography (OCT) to assess scleral integrity - Blood tests to identify underlying autoimmune or inflammatory conditions - Detailed medical history to determine predisposing factors or previous eye trauma or surgeries
Treatment Protocols: Managing scleromalacia perforans focuses on halting progression and preventing complications. Treatment options may include: - Immunosuppressive therapy or corticosteroids to control underlying autoimmune inflammation - Regular monitoring to observe disease progression - Surgical interventions such as scleral grafts or patches in cases of scleral perforation or thinning severe enough to threaten eye integrity - Addressing associated conditions like rheumatoid arthritis with appropriate systemic therapy - Protective measures to avoid trauma and maintain eye health - In some cases, no active treatment is necessary if the condition remains stable and asymptomatic, but close observation is essential
Clinical Advice & FAQs
Billing Guidance
Is H15.05 a billable ICD-10 code?
Yes, H15.05 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report H15.05?
Clinical documentation must specify the nature of Scleromalacia perforans and any associated comorbidities for accurate reporting.
Cite this Clinical Reference